Freezing cells is treated as storage, which is the root of most of what goes wrong with it. Storage implies the cells wait, unchanged, until called upon. What actually happens is a process the cell has to survive, and the population that comes out is not a random sample of the population that went in.
The three things that kill cells during a freeze
Ice formation is the obvious one, and the important distinction is where it forms. Extracellular ice is survivable. Intracellular ice generally is not, because crystals disrupt membranes and organelles from the inside.
Solute concentration is the second and subtler mechanism. As water leaves the liquid phase to form ice, everything dissolved in the remaining water becomes progressively more concentrated, and cells sit in an increasingly hostile solution while osmotic gradients pull water across the membrane.
The third is the cryoprotectant itself. DMSO prevents the first two problems by moderating ice formation and it is toxic to cells at room temperature. Every minute between adding it and getting the cells cold is a cost, which is why handling time is a variable rather than an incidental detail.
Rate is the compromise between them
Cooling slowly enough allows water to leave the cell before it can freeze inside, which avoids intracellular ice but extends exposure to concentrated solutes. Cooling quickly limits solute exposure but leaves water inside to crystallise. The conventional target of roughly one degree per minute sits between the two failure modes rather than at an optimum.
A controlled-rate freezer holds that curve deliberately and records it. An insulated container in a mechanical freezer approximates it, works acceptably for many applications, and produces no record. Which of those is appropriate depends on whether you will later need to demonstrate what actually happened.
Related product
Cryopreserved PBMCs. Single-donor PBMCs in current catalogue formats, with the donor record attached.
Not every cell in the tube fares equally
| Population | Tolerance | Consequence |
|---|---|---|
| Lymphocytes broadly | Good | Recover well and dominate the thawed preparation |
| Monocytes | Poor | Recovered below input frequency, which shifts subset ratios |
| Dendritic cell precursors | Poor | Downstream differentiation suffers before you start |
| Granulocytes | Very poor | Largely lost, which is occasionally convenient and otherwise adds debris |
The practical implication is that a thawed PBMC preparation is subtly enriched for lymphocytes relative to the fresh preparation it came from. If your analysis assumes input frequencies, it is already wrong by that margin.
Where the avoidable errors sit
Adding cryoprotectant warm and then working slowly is the most common. Cell concentration outside a sensible range is the second, too dense and the cells cannot shed water, too dilute and yield suffers. Uneven cooling from overfilled racks is third. Transferring to long-term storage late, so vials sit in a transitional temperature for hours, is fourth and the most invisible.
Storage temperature is not a detail
Cryopreserved cells should be held below the glass transition temperature of the freezing medium, which is why vapor-phase liquid nitrogen is the reference condition rather than a mechanical freezer. Above that threshold molecular mobility resumes and ice recrystallises slowly, damaging cells over weeks and months in a way that will not be apparent until they are thawed.
OrganaBio documents vapor-phase liquid nitrogen storage for cryopreserved formats across the leukopak portfolio and for isolated populations including cryopreserved PBMCs.
Freeze it yourself, or buy it frozen
Freezing in house is worth it when the protocol is part of the study, when a non-standard medium is required, or when the material has to be banked at a specific point in your own process. It is worth less when it is simply a step between receipt and experiment, because every variable in this article then becomes yours to control and to explain.
Choosing between formats is covered in the fresh versus cryopreserved guide, and what happens on the other side is in the thawing protocol.
Frequently asked questions
Why is a cooling rate of about one degree per minute used for PBMCs?
It sits between two failure modes. Cooling more slowly gives water time to leave the cell but extends exposure to increasingly concentrated solutes. Cooling faster limits solute exposure but leaves water inside to form intracellular ice. The conventional rate is a compromise rather than an optimum.
Why is DMSO handling time so important?
DMSO prevents damaging ice formation and is itself toxic to cells at room temperature. Every minute between adding cryoprotectant and getting the cells cold carries a cost, so cold addition and prompt transfer to the freezing device matter more than most later steps.
Which PBMC populations survive freezing least well?
Monocytes and dendritic cell precursors recover poorly, and granulocytes are largely lost. Lymphocytes tolerate it well, so a thawed preparation is subtly enriched for lymphocytes compared with the fresh preparation it came from.
Do I need a controlled-rate freezer?
A controlled-rate freezer holds the cooling curve deliberately and records it. An insulated container in a mechanical freezer approximates the curve and works acceptably for many applications but produces no record. The choice depends on whether you will later need to demonstrate what happened.
Why must cryopreserved cells be stored in vapor-phase liquid nitrogen?
Because cells should be held below the glass transition temperature of the freezing medium. Above it, molecular mobility resumes and ice recrystallises slowly, accumulating damage over weeks and months that only becomes apparent on thaw.
What is the most common avoidable cryopreservation error?
Adding cryoprotectant warm and then working slowly. Others include cell concentrations outside a sensible range, uneven cooling from overfilled racks, and delayed transfer to long-term storage leaving vials at a transitional temperature.
Should I freeze PBMCs myself or buy them cryopreserved?
Freezing in house is worthwhile when the protocol is part of the study, a non-standard medium is needed, or material must be banked at a specific point in your own process. Otherwise every variable in the freeze becomes yours to control and to explain.
Talk to OrganaBio
Need this material for a specific process?
Formats, vial sizes and donor characterization vary by product, and custom formats are documented where a process needs them. Tell us what your process requires and the scientific team will confirm what can be supplied.
